Achillion to Present at the Barclays Global Healthcare Conference
08 March 2018 - 10:05PM
Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN)
announced today that Milind Deshpande, Ph.D., Chief Executive
Officer of Achillion, will present a corporate overview at the
Barclays Global Healthcare Conference on Thursday, March 15, 2018,
at 11:15 a.m. ET at the Loews Miami Beach Hotel in Miami, FL.
The live audio and subsequent archived webcasts
of the Company's presentations will be accessible from the
Company's investor relations website, http://ir.achillion.com. The
audio recording will be archived for 30 days following the live
presentation. Please connect to Achillion's website several minutes
prior to the start of the presentation to ensure adequate time for
any software downloads that may be necessary.
About Achillion
Pharmaceuticals
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) is
a science-driven, patient-focused company seeking to leverage its
capabilities across the continuum from discovery to
commercialization in its goal of providing better treatments for
people with serious diseases. The company employs a
highly-disciplined discovery and development approach that has
allowed it to build a platform of potent and specific complement
factor D inhibitors for AP-mediated diseases. Achillion is rapidly
advancing its efforts to bring life-saving medicines to patients
with rare diseases. More information is available
at http://www.achillion.com.
Investors & Media:
Glenn Schulman, PharmD, MPH
Achillion Pharmaceuticals, Inc.
Tel. (203) 752-5510
gschulman@achillion.com
Achillion Pharmaceuticals (NASDAQ:ACHN)
Historical Stock Chart
From Apr 2024 to May 2024
Achillion Pharmaceuticals (NASDAQ:ACHN)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Achillion Pharmaceuticals Inc (NASDAQ): 0 recent articles
More News Articles